Americans' Health Priorities During the COVID-19 Pandemic.


Journal

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
ISSN: 1524-4733
Titre abrégé: Value Health
Pays: United States
ID NLM: 100883818

Informations de publication

Date de publication:
08 2022
Historique:
received: 05 02 2021
revised: 24 12 2021
accepted: 17 01 2022
pubmed: 30 4 2022
medline: 10 8 2022
entrez: 29 4 2022
Statut: ppublish

Résumé

This study aimed to examine how Americans' opinions of the seriousness of various health-related problems have changed over time and to quantify the public's preferences for research prioritization. We conducted a survey that asked respondents to rate the seriousness of 80 health-related problems on a 4-point Likert scale ("very serious problem," "somewhat serious problem," "not too serious of a problem," or "not a problem at all"). Results were compared with past surveys from 2001 and 2013 that examined the same set of health-related problems (with the exception of COVID-19). The survey also included best-worst scaling questions that asked respondents to select, from 20 health problems, those they considered most and least important for research funding. Respondents were recruited from the KnowledgePanel, a nationally representative sample of American households. A total of 768 adults completed the survey between September 3, 2020, and September 14, 2020. The health-related problems that Americans consider to be "very serious" generally align with the leading causes of death and noncommunicable diseases such as heart disease, diabetes, and mental health; nevertheless, several social determinants of health are also identified. COVID-19 was an unsurprising top priority, whereas cancer remains the highest and a persistent priority for research funding. Americans consider a diverse set of health-related problems to be "very serious," with recognition of social determinants of health rising. Our findings offer guidance as to the disease areas for which the public would value further public and private investment in treatment innovations.

Identifiants

pubmed: 35487822
pii: S1098-3015(22)00098-5
doi: 10.1016/j.jval.2022.01.021
pmc: PMC9040533
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1281-1289

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Références

MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1717-1724
pubmed: 33211683
Am J Public Health. 2003 Nov;93(11):1945-52
pubmed: 14600071
Pharmacoeconomics. 2016 Dec;34(12):1195-1209
pubmed: 27402349
Violence Against Women. 2020 Jul 6;:1077801220935194
pubmed: 32627703
Natl Vital Stat Rep. 2017 Nov;66(5):1-76
pubmed: 29235984
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Natl Vital Stat Rep. 2015 Aug 31;64(10):1-93
pubmed: 26759854
Natl Vital Stat Rep. 2011 Aug 26;59(8):1-95
pubmed: 21950210
Neuropsychiatr Dis Treat. 2019 Feb 22;15:603-609
pubmed: 30863081
Health Aff (Millwood). 2001 Nov-Dec;20(6):222-32
pubmed: 11816663
J Health Soc Behav. 2020 Dec;61(4):398-417
pubmed: 33211540
JAMA. 2020 Oct 13;324(14):1381-1383
pubmed: 32965460
BMJ Glob Health. 2017 Dec 1;3(Suppl 1):e000603
pubmed: 29379648
Health Aff (Millwood). 2006 Nov-Dec;25(6):w508-15
pubmed: 17046841
MMWR Morb Mortal Wkly Rep. 2021 Apr 09;70(14):519-522
pubmed: 33830988
Prev Med. 2012 May;54 Suppl:S29-37
pubmed: 22178471

Auteurs

Joseph Cook (J)

Viatris, Canonsburg, PA, USA.

Melissa Pittaoulis (M)

NERA Economic Consulting, Philadelphia, PA, USA. Electronic address: melissa.pittaoulis@nera.com.

Kim Gilchrist (K)

Viatris, Canonsburg, PA, USA.

Justine Alderfer (J)

Pfizer, Inc, Collegeville, PA, USA.

Molly Sapia (M)

NERA Economic Consulting, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH